Program News
News and stories about members of the UNC Lineberger Immunology Research Program
-
Scientific symposium highlights latest developments in pancreatic cancer research
UNC Lineberger’s 47th annual scientific symposium featured 17 presentations from faculty at UNC Lineberger and institutions across the United States.
-
UNC researchers to present at American Society of Clinical Oncology annual meeting
UNC and UNC Lineberger researchers and trainees will be presenting talks and participating in scientific and educational panels and discussions on the latest cancer research at the ASCO Annual Meeting.
-
UNC School of Medicine Names 2023-24 Yang Family Biomedical Scholars
UNC Lineberger’s Pengda Liu, PhD, and Benjamin Vincent, MD, were selected as Yang Family Biomedical Scholars in the eighth installment of this annual School of Medicine award.
-
UNC researchers present at American Association for Cancer Research’s 115th Annual Meeting
Researchers and trainees from UNC and UNC Lineberger at will present more than 30 talks and participate in scientific and educational panels and discussions on the latest cancer research.
-
Newly engineered molecule bypasses toxicity previously found in key cancer-fighting pathway
UNC Lineberger researchers have developed a molecule that is much more effective than a previously identified molecule at activating a biological pathway and spurring a strong anti-cancer immune response in preclinical studies.
-
Curated cancer care
UNC Lineberger researchers are using CAR-T to create better and personalized cancer treatments in one of the largest cell therapy facilities on the East Coast.
-
Cancer center researchers to present latest findings at international breast cancer meeting
The San Antonio Breast Cancer Symposium features presentations outlining basic, translational, clinical and community-based study findings focused on advancing the prevention, diagnosis and treatment of breast cancer.
-
UNC Lineberger faculty named world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2023 Highly Cited Researchers™ list, which recognized scientists who published papers that ranked in the top 1% of cited publications in their field between 2012-2022.
-
Treatment-resistant infections, a “slow-moving catastrophe”
David van Duin, MD, PhD, and colleagues at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections.
-
Thomas C. Shea Clinical Cancer Symposium brings together national leaders in blood cancers
The inaugural symposium featured talks on adoptive cellular therapy for lymphoid malignancies and novel approaches for the treatment of acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms.
-
Rooted: Ilona Jaspers
UNC Lineberger member Ilona Jaspers, MS, PhD, has been contributing to research at Carolina for 26 years.
-
Gut microbiome can increase risk, severity of HIV, EBV disease
UNC researchers report that the gut microbiome has a significant impact on the acquisition of Epstein-Barr virus and human immunodeficiency virus-1 infection and plays a role in the course of disease.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
NCI awards Earp, Pylayeva-Gupta five-year, $2.69 million pancreatic cancer research grant
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
-
Why don’t T cells destroy solid tumors during immunotherapy?
Jessica Thaxton, PhD, MsCR, and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.